LUXEMBOURG, April 27, 2026--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer | Identify code of the Issuer | Transaction day | Identify code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
EUROFINS SCIENTIFC | 529900JEHFM47DYY3S57 | 23/04/2026 | FR0014000MR3 | 40 000 | 61.8744 | XPAR |
EUROFINS SCIENTIFC | 529900JEHFM47DYY3S57 | 23/04/2026 | FR0014000MR3 | 10 000 | 61.9124 | CEUX |
EUROFINS SCIENTIFC | 529900JEHFM47DYY3S57 | 24/04/2026 | FR0014000MR3 | 5 000 | 62.4335 | CEUX |
EUROFINS SCIENTIFC | 529900JEHFM47DYY3S57 | 24/04/2026 | FR0014000MR3 | 35 000 | 62.3608 | XPAR |
|
|
| TOTAL | 90 000 | 62.0988 |
|
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes
View source version on businesswire.com: https://www.businesswire.com/news/home/20260427550178/en/
Contacts
Eurofins Scientific SE